佛慈制药
(002644)
| 流通市值：39.01亿 | | | 总市值：39.01亿 |
| 流通股本：5.11亿 | | | 总股本：5.11亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 650,224,311.46 | 440,320,280.34 | 211,574,701.05 | 915,533,598.79 |
| 营业总成本 | 590,151,686.86 | 394,915,425.87 | 183,095,248.39 | 813,851,221.73 |
| 其他经营收益 | | | | |
| 营业利润 | 63,096,563.55 | 45,697,247.22 | 27,124,980.34 | 65,985,504.49 |
| 利润总额 | 59,879,045.29 | 44,416,206.06 | 27,032,897.22 | 65,030,429.01 |
| 净利润 | 49,320,353.56 | 37,955,735.58 | 22,871,613.71 | 46,955,016.44 |
| 每股收益 | | | | |
| 其他综合收益 | -156,937.64 | -156,937.64 | - | -90,160.47 |
| 综合收益总额 | 49,163,415.92 | 37,798,797.94 | 22,871,613.71 | 46,864,855.97 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,440,157,778.46 | 1,422,063,804.33 | 1,363,162,459.43 | 1,332,741,137.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,181,989,998.96 | 1,198,090,300.65 | 1,200,293,721.98 | 1,214,755,339.92 |
| 资产总计 | 2,622,147,777.42 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 |
| 流动负债: | | | | |
| 流动负债合计 | 489,040,398.91 | 493,537,485.05 | 447,842,745.85 | 440,621,459.18 |
| 非流动负债: | | | | |
| 非流动负债合计 | 240,449,225.31 | 243,601,077.37 | 247,030,319.21 | 251,410,753.04 |
| 负债合计 | 729,489,624.22 | 737,138,562.42 | 694,873,065.06 | 692,032,212.22 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,873,053,317.37 | 1,862,079,336.11 | 1,845,324,107.5 | 1,832,669,317.64 |
| 股东权益合计 | 1,892,658,153.2 | 1,883,015,542.56 | 1,868,583,116.35 | 1,855,464,264.81 |
| 负债和股东权益合计 | 2,622,147,777.42 | 2,620,154,104.98 | 2,563,456,181.41 | 2,547,496,477.03 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 776,577,337.38 | 538,829,847.95 | 233,494,128.1 | 943,398,933.27 |
| 经营活动现金流出小计 | 584,068,617.74 | 378,470,479.19 | 177,506,557.23 | 759,449,585.8 |
| 经营活动产生的现金流量净额 | 192,508,719.64 | 160,359,368.76 | 55,987,570.87 | 183,949,347.47 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | 392,671.23 | - | 270,312.73 |
| 投资活动现金流出小计 | 28,464,290.86 | 25,677,935.83 | 1,798,162.19 | 38,567,318.98 |
| 投资活动产生的现金流量净额 | -28,464,290.86 | -25,285,264.6 | -1,798,162.19 | -38,297,006.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 2,000,000 | 2,000,000 | 0 | 16,000,000 |
| 筹资活动现金流出小计 | 37,021,705.79 | 26,952,261.34 | 13,439,233.33 | 31,852,925.38 |
| 筹资活动产生的现金流量净额 | -35,021,705.79 | -24,952,261.34 | -13,439,233.33 | -15,852,925.38 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | -188,980.2 |
| 现金及现金等价物净增加额 | 129,022,722.99 | 110,121,842.82 | 40,750,175.35 | 129,610,435.64 |
| 期末现金及现金等价物余额 | 653,515,288.96 | 634,614,408.79 | 565,242,741.32 | 524,492,555.97 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 110,121,842.82 | - | 129,610,435.64 |